DurgicalDurgical
EN
Open the app

Prochlorperazine !

A phenothiazine that blocks dopamine in the vomiting centre. It controls severe nausea but can cause dystonia, low blood pressure and sedation.

Updated 2026-11-01

No structure of prochlorperazine bound to D2 exists; the figure shows haloperidol, another antipsychotic, in the same dopamine pocket of the human D2 receptor.

Target in 3D: Dopamine D2 receptor. PDB structure 6LUQ (RCSB PDB, public domain). View the structure at RCSB PDB

Mechanism of action

Prochlorperazine is a piperazine phenothiazine. Like the other phenothiazines it blocks dopamine D2 receptors in the chemoreceptor trigger zone, which depresses the vomiting reflex, and it also has an antipsychotic effect. It blocks α-adrenergic receptors and has anticholinergic effects, which explain low blood pressure, blurred vision and dry mouth.

  1. Blocks D2 receptors in the chemoreceptor trigger zone
  2. The vomiting reflex is depressed: less nausea
  3. α1 block and anticholinergic effects add hypotension and dry mouth
  4. D2 block in the basal ganglia causes dystonia and akathisia

Pharmacokinetics

Absorption
Given by mouth (tablets), rectally (suppositories), intramuscularly or intravenously.
Onset and duration
After an intramuscular dose it acts within 10–20 minutes and lasts about 3–4 hours.

Indications

Adverse effects

Common

  • Drowsiness and dizziness
  • Low blood pressure, especially after injection
  • Blurred vision and dry mouth
  • Amenorrhoea and skin reactions

Contraindications

  • Hypersensitivity to phenothiazines
  • Coma or large amounts of CNS depressants (alcohol, barbiturates, opioids)
  • Children under 2 years or under the weight set in the label
  • Bone marrow depression or a prior blood dyscrasia or jaundice from a phenothiazine (unless benefit clearly outweighs risk)

Key interactions

Alcohol, anaesthetics, opioids and other CNS depressants
Deeper and longer sedation.
Epinephrine
Phenothiazines block α receptors, so epinephrine can lower blood pressure further; norepinephrine or phenylephrine are used if a vasopressor is needed.
Thiazide diuretics and antihypertensives
More orthostatic hypotension.
Propranolol
Higher levels of both drugs.
Anticonvulsants and phenytoin
Lower seizure threshold, and phenytoin toxicity reported.
Lithium
Rare encephalopathic syndrome with antipsychotics.

What is monitored

  • Blood pressure lying and standing, especially after injection
  • Abnormal movements (dystonia, akathisia, tardive dyskinesia)
  • Complete blood count in patients with low white cells or prior drug-induced neutropenia
  • Temperature and muscle rigidity (neuroleptic malignant syndrome)

Administration and safety

  • Not given subcutaneously, because it irritates the tissue
  • After an injection the patient stays lying down and is observed for at least half an hour because of hypotension
  • Staff avoid skin contact with the solution, which can cause contact dermatitis
  • Its antiemetic effect can mask intestinal obstruction, brain tumour or overdose of other drugs

Nursing care

  • Check blood pressure before and after an injection and help the patient up slowly
  • Watch for twisted neck, jaw spasm, restlessness or eye deviation after the dose
  • Warn about drowsiness and falls, especially in older adults
  • Ask about alcohol and other sedatives
  • Teach the patient to report fever, sore throat or yellow skin

Pregnancy and breastfeeding

Newborns whose mothers received phenothiazines have shown prolonged jaundice and extrapyramidal signs; it is used only when clearly needed.

Test yourself

Think of the answer, then tap the question to see it.

Why is epinephrine avoided to treat hypotension caused by prochlorperazine?

Phenothiazines block α receptors, so epinephrine's β2 vasodilation predominates and blood pressure can fall further; norepinephrine or phenylephrine are used instead.

Why does a patient stay lying down after an intramuscular dose of prochlorperazine?

It can cause hypotension through α1-adrenergic block; the patient is observed for at least half an hour.

Which receptor explains prochlorperazine's antiemetic effect?

The dopamine D2 receptor in the chemoreceptor trigger zone.

Add to my cards (3)

← Back to the class: Dopamine-antagonist antiemetics and prokinetics

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - PROCHLORPERAZINE EDISYLATE injection (DailyMed (U.S. National Library of Medicine), 2026); Prochlorperazine: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); RCSB PDB - 6LUQ: Haloperidol bound D2 dopamine receptor structure inspired discovery of subtype selective ligands (RCSB Protein Data Bank, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.